Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_assertion type Assertion NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_head.
- NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_assertion description "[These findings have significant implications for developing effective therapies for myeloid leukemias and offer a strategy to inhibit the oncogenic functions of WT1 by clinically available Hsp90 inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_provenance.
- NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_assertion evidence source_evidence_literature NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_provenance.
- NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_assertion SIO_000772 20651072 NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_provenance.
- NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_assertion wasDerivedFrom befree-2016 NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_provenance.
- NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_assertion wasGeneratedBy ECO_0000203 NP827601.RAO5XPWQ0qaV6U7guXK1sMe1EuW-HdM08dbyHv_cblZhc130_provenance.